• A report highlighting the disparities and barries to treatment of opoid use disorder in 2022, was recently published. 

• In 2022, only 25% of U.S. adults needing Opioid Use Disorder (OUD) treatment received recommended medications, while 30% received treatment without them.

• Disparities exist, with higher percentages of white adults receiving any OUD treatment compared to Black or Hispanic adults.

• Men and adults aged 35–49 were more likely to receive medications than women and other age groups.

• To improve public health outcomes, there is a need for increased communication about the effectiveness of OUD medications and for healthcare providers to offer evidence-based treatments, including medications.

• Barriers to medication access include clinician preferences, regulatory issues, and lack of availability in pharmacies.

• This report underscores the underuse of OUD medications and the demographic disparities in treatment, highlighting the need to address these challenges.

Click here to read more.